ST嘉必优 (688089.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

44.2x

EV/EBITDA

6.6x

Market Cap

CNY 1.26B

MomentumView details →

1D Return

+0.67%

YTD Return

—

RSI (14)

54.7

ValuationView details →

P/E (Fwd)

44.2x

EV/EBITDA

6.6x

Market Cap

CNY 1.26B

RSI (14)

54.7

MomentumView details →

1D Return

+0.67%

YTD Return

—

ProfitabilityView details →

Gross Margin

43.41%

Net Margin

13.19%

EBITDA Margin

50.80%

ROE (TTM)

3.47%

ROA (TTM)

2.87%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

−29.66%

EPS YoY

−62.12%

FCF YoY

+381.93%

Revenue CAGR 3Y

+9.12%

EPS CAGR 3Y

+31.29%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.34

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−CNY 0.08

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

3.76x

Quick Ratio

2.80x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.47%

Financials snapshotView financials →

Revenue (TTM)

418.18M

Net Income (TTM)

55.16M

Op. CF (TTM)

224.45M

Next earningsOct 26, 2026 →

Latest newsMore news →

No recent news for 688089.SH.

Similar companies

Jade Biosciences, Inc.JBIO Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.02566.HK MoonLake ImmunotherapeuticsMLTX Janux Therapeutics, Inc.JANX MannKind CorporationMNKD Corvus Pharmaceuticals, Inc.CRVS Find similar companies →

Latest newsMore news →

No recent news for 688089.SH.